miglustat has been researched along with n-nonyl-1-deoxynojirimycin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, I; Asano, N; Compain, P; Godin, G; Ikeda, K; Kato, A; Martin, O; Yu, L | 1 |
| Block, TM; Bourne, N; Chang, J; Gu, B; Guo, H; Guo, JT; Ma, D; Mason, PM; Moriarty, R; Qu, X; Wang, L; Xu, X | 1 |
| Butters, TD; Reinkensmeier, G; Wang, GN; Ye, XS; Zhang, LH; Zhang, LR; Zhang, SW; Zhou, J | 1 |
| Bujons, J; Casas, J; Delgado, A; Díaz, L; Llebaria, A | 1 |
| Allman, S; Butters, TD; Jensen, HH; Rasmussen, TS; Twigg, G | 1 |
| Codd, R; Liao, V; Lifa, T; Liu, J; Obando, D | 1 |
| Benjamin, ER; Boyd, RE; Khanna, R; Lee, G; Rybczynski, P; Valenzano, KJ; Wustman, BA | 1 |
| Aerts, JM; Bikker, P; Boot, R; de Bruijn, AC; Donker-Koopman, WE; Ghisaidoobe, A; Godschalk, FD; Guijt, MC; Hagens, P; Halma, JM; Luitjens, SB; Overkleeft, HS; Rogaar, E; Strijland, A; van den Berg, RJ; van der Marel, G; van Rixel, VH; Van't Hart, SM; Wijzenbroek, M; Zweegers, T | 1 |
| Block, TM; Chang, J; Du, Y; Guo, F; Guo, J; Guo, JT; Kinney, W; Lam, P; Li, Y; Lu, H; Ma, J; Su, Q; Wu, S; Yan, Z; Yang, K; Zhang, X | 1 |
| Aureli, M; Bassi, R; Bragonzi, A; Cabrini, G; D'Alonzo, D; De Fenza, M; De Fino, I; Dechecchi, MC; Esposito, A; Gambari, R; Guaragna, A; Lampronti, I; Lippi, G; Loberto, N; Munari, S; Palumbo, G; Ranucci, S; Rossi, A; Santangelo, A; Tamanini, A; Tironi, M | 1 |
| Gu, Y; Harvey, DJ; Hussain, S; McCauley, JW; Miller, JL; Rosenthal, PB; Zitzmann, N | 1 |
2 review(s) available for miglustat and n-nonyl-1-deoxynojirimycin
| Article | Year |
|---|---|
The many faces of the adamantyl group in drug design.
Topics: Adamantane; Animals; Antimalarials; Diabetes Mellitus, Type 2; Drug Design; Humans; Hypoglycemic Agents; Iron Chelating Agents; Iron Overload; Malaria; Solubility | 2011 |
Pharmacological chaperones as therapeutics for lysosomal storage diseases.
Topics: Cell Line; Glycolipids; Humans; Lysosomal Storage Diseases; Molecular Chaperones; Structure-Activity Relationship | 2013 |
9 other study(ies) available for miglustat and n-nonyl-1-deoxynojirimycin
| Article | Year |
|---|---|
Alpha-1-C-octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease.
Topics: 1-Deoxynojirimycin; Cell Line; Dose-Response Relationship, Drug; Gaucher Disease; Glucosamine; Glucosylceramidase; Humans; Molecular Chaperones; Molecular Mimicry; Structure-Activity Relationship | 2006 |
Novel imino sugar derivatives demonstrate potent antiviral activity against flaviviruses.
Topics: 1-Deoxynojirimycin; Animals; Antiviral Agents; Cattle; Cell Line; Cricetinae; Flavivirus; Glycoside Hydrolase Inhibitors; Imino Sugars; Structure-Activity Relationship | 2009 |
Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant Gaucher disease.
Topics: Drug Design; Gaucher Disease; Glucosylceramidase; Humans; Imino Sugars; Lactams; Mutation, Missense; Structure-Activity Relationship; Substrate Specificity | 2009 |
Click chemistry approach to new N-substituted aminocyclitols as potential pharmacological chaperones for Gaucher disease.
Topics: Cyclitols; Gaucher Disease; Glucosylceramidase; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Structure-Activity Relationship; Triazoles | 2010 |
Synthesis of N-alkylated noeurostegines and evaluation of their potential as treatment for Gaucher's disease.
Topics: Enzyme Assays; Gaucher Disease; Glucosylceramidase; Humans; Inhibitory Concentration 50; Nortropanes | 2011 |
Identification of potent and selective glucosylceramide synthase inhibitors from a library of N-alkylated iminosugars.
Topics: | 2011 |
Ester Prodrugs of IHVR-19029 with Enhanced Oral Exposure and Prevention of Gastrointestinal Glucosidase Interaction.
Topics: | 2017 |
Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; beta-Glucosidase; Bronchi; Cystic Fibrosis; Dose-Response Relationship, Drug; Humans; Imino Sugars; Inflammation; Inhibitory Concentration 50; Mice; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Stereoisomerism | 2019 |
Strain-specific antiviral activity of iminosugars against human influenza A viruses.
Topics: 1-Deoxynojirimycin; Antiviral Agents; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Microbial Sensitivity Tests; Virus Replication | 2015 |